semaglutide cardiovascular outcomes news today HUGE NEWS! Contrary to popular belief: GLP-1 weight loss medications are NOT all about aesthetics, they REDUCE risk of death, heart attack, stroke, heart failure, AND ALL CAUSE MORTALITY! Groundbreaking SELECT Semaglutide, inflammatory markers and cardiovascular

But Novo said in the suit that a more recent study shows that the high-dose 7.2-milligram dose of Wegovy helped patients lose 47 pounds on average, which is "clinically consistent" with Zepbound's weight loss in Lilly's most recent rigorous trial on the drug

Hydration: Ensure adequate water intake to support overall health and assist the body in detoxification

The Chicago-based company also released a new report on frozen food trends for the new year, highlighting Americas increased appetite for spice, heat, and indulgent in-home dining experiences

thus, GLP-1RAs are favorable candidates for repurposing for the treatment of neurodegenerative diseases